61 results
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
5 Mar 24
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
713mg/day 8 Goals of a new treatment Limitations of current treatments Endpoints Rapid cessation Maintenance of seizure control Prevent progression … to IV anesthesia within 36 hrs Responder analysis: SE cessation within 30 min and no escalation of care within 36 hrs Trial Goals: Support potential
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
4 Jan 24
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 ZTALMY® Net Product Revenue and Provides Business Update
7:04am
Goals Target Oral Pharmacokinetic Profile Increase efficacy Consistent delivery to achieve target plasma concentration Improve tolerability Optimize PK … Prodrug Oral prodrug candidate selected Goals: Optimize PK parameters for efficacy, tolerability and dosing frequency Increase absorption (oral
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
28 Nov 23
Other Events
7:05am
Pharmaceuticals. All Rights Reserved I Second Generation Ganaxolone 19 Goals Target Oral Pharmacokinetic Profile Increase efficacy Consistent delivery to achieve … candidate selected Goals: Optimize PK parameters for efficacy, tolerability and dosing frequency Increase absorption (oral), solubility (IV) Preclinical IND
8-K
EX-99.2
qzj8h8s
7 Nov 23
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
7:11am
8-K
EX-99.1
revocav4sbzyo2
28 Sep 23
Other Events
7:05am
8-K
EX-99.2
7fgel x6fo
10 Aug 23
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
7:10am
8-K
EX-99.1
inck0d87n4 xftz67v6t
17 May 23
Departure of Directors or Certain Officers
4:02pm
8-K
EX-99.2
5tzv el6et3bnce
11 May 23
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
pkcbxm7y7hva an4n
5 Dec 22
Other Events
9:00am
8-K
EX-99.1
490ztis6w2z5wm2
7 Nov 22
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:01pm
8-K
EX-99.2
y1xj9r
7 Nov 22
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:01pm
8-K
EX-99.2
46zx9 h7ckcv1jv6q
11 Aug 22
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
7:33am
8-K
EX-10.1
zptscy arp8
14 Jul 22
Entry into a Material Definitive Agreement
7:11am
8-K
EX-99.2
myeop
21 Mar 22
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
7:16am
8-K
EX-99.2
ee7wzekid24vg8z
9 Nov 21
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
7:03am